Lung Cancer Screening Results: Easily Misunderstood

Midthun, David E.; Swensen, Stephen J.; Hartman, Thomas E.; Jett, James R.
January 2007
Mayo Clinic Proceedings;Jan2007, Vol. 82 Issue 1, p14
Academic Journal
The author reflects on the report on lung cancer screening by the International Early Lung Cancer Action Project (IELCAP) group published in "The New England Journal of Medicine." According to the author, observational studies such as the IELCAP can provide important information but cannot prove efficacy of screening through mortality reduction. He said that the improved survival reported by the IELCAP group may simply be a reflection of bias from screening.


Related Articles

  • DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer. Zheng, Zhong; Chen, Tingan; Li, Xueli; Haura, Eric; Sharma, Anupama; Bepler, Gerold // New England Journal of Medicine;2/22/2007, Vol. 356 Issue 8, p800 

    Background: RRM1, the regulatory subunit of ribonucleotide reductase, is involved in carcinogenesis, tumor progression, and the response of non–small-cell lung cancer to treatment. Methods: We developed an automated quantitative determination of the RRM1 protein in routinely processed...

  • Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results. Jakobsen, Erik; Palshof, Torben; Østerlind, Kell; Pilegaard, Hans // European Journal of Cardio-Thoracic Surgery;Feb2009, Vol. 35 Issue 2, p348 

    Abstract: Objective: In 1998 The Danish Lung Cancer Group published the first edition of guidelines for diagnosis and treatment of lung cancer. A national registry was implemented in the year 2000 with the primary objective to monitor the implementation of these guidelines and nationwide to...

  • Lung cancer invading the fissure to the adjacent lobe: more a question of spreading mode than a staging problem. Riquet, Marc; Berna, Pascal; Arame, Alex; Mordant, Pierre; Das Neves Pereira, Joao Carlos; Foucault, Christophe; Dujon, Antoine; Le Pimpec Barthes, Françoise // European Journal of Cardio-Thoracic Surgery;May2012, Vol. 41 Issue 5, p1047 

    OBJECTIVES Lung cancer invading beyond the interlobar pleura, classified as T2a in the new TNM, is a rare entity with a poor outcome. Our purpose was a better understanding of the mechanisms of this particular behaviour and its prognostic value. METHODS Patients who underwent surgery between...

  • Neoadjuvant Chemotherapy for Non-Small-Cell Lung Cancer: Does It Really Impact on Postoperative Outcome After Lung Resection? Voltolini, L.; Rapicetta, C.; Ligabue, T.; Scolletta, S.; Ghiribelli, C.; Gotti, G. // European Journal of Clinical & Medical Oncology;2011, Vol. 3 Issue 2, p57 

    BACKGROUND Although some studies seem to indicate a positive prognostic value of induction chemotherapy in patients with locally advanced Non-Small-Cell Lung Cancer (NSCLC), its impact on postoperative mortality and morbidity is not well established. MATERIALS AND METHODS We reviewed the records...

  • Disparities in Access to Video-Assisted Thoracic Surgical Lobectomy for Treatment of Early-Stage Lung Cancer. Stitzenberg, Karyn B.; Shah, Prashant C.; Snyder, Justin A.; Scott, Walter J. // Journal of Laparoendoscopic & Advanced Surgical Techniques;Oct2012, Vol. 22 Issue 8, p753 

    Background: Video-assisted thoracic surgical (VATS) lobectomy was originally described in 1992 and has slowly gained increasing acceptance. This study documents current utilization and outcomes for VATS versus open lobectomy in three Mid-Atlantic states. Subjects and Methods: Inpatient discharge...

  • National trends in lung cancer surgery. Strand, Trond-Eirik; Bartnes, Kristian; Rostad, Hans // European Journal of Cardio-Thoracic Surgery;Aug2012, Vol. 42 Issue 2, p355 

    OBJECTIVES Trends in lung cancer surgery may reveal potential for improvement and are important for planning by care providers. METHODS Using data from the Cancer Registry of Norway, we analysed the outcomes of lung cancer surgery during the periods of 1994–95, 2000–01 and...

  • Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy†. Storelli, Erica; Tutic, Michaela; Kestenholz, Peter; Schneiter, Didier; Opitz, Isabelle; Hillinger, Sven; Weder, Walter // European Journal of Cardio-Thoracic Surgery;Jul2012, Vol. 42 Issue 1, p77 

    OBJECTIVES Sleeve resection is the operation of choice in patients with centrally located tumours, in order to avoid a pneumonectomy. Most surgeons protect the bronchial anastomoses with tissue to prevent insufficiencies. The purpose of this study is to report on outcome of unwrapped bronchial...

  • Re: The burden of death following discharge after lobectomy. Falcoz, Pierre-Emmanuel // European Journal of Cardio-Thoracic Surgery;Jul2015, Vol. 48 Issue 1, p70 

    The author reflects on the study "The burden of death following discharge after lobectomy," by L. Schneider and colleagues, focusing on the postoperative mortality for patients who underwent lobectomy lung cancer. Topics discussed include the in-hospital mortality (IHM) and post-discharge...

  • Assessment of whether in-hospital mortality for lobectomy is a useful standard for the quality of lung cancer surgery: retrospective study. Treasure, Tom; Utley, Martin; Bailey, Alan // BMJ: British Medical Journal (International Edition);7/12/2003, Vol. 327 Issue 7406, p73 

    Objectives: To calculate in-hospital mortality after lobectomy for primary lung cancer in the United Kingdom to explore the validity of using such data to assess the quality of UK thoracic surgeons; and to investigate the relation between in-hospital mortality and the number of procedures...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics